BioCentury
ARTICLE | Clinical News

CDP840: Completed a Phase I trial

May 23, 1994 7:00 AM UTC

Celltech Group plc (U.K.) Product: CDP840 orally active phosphodiesterase IV inhibitor Indication: Mild or moderate asthma Status: Completed a Phase I trial in 32 healthy subjects in the U.K; Phase II...